J&J To Focus On Small-To-Medium Size Acquisitions
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite speculation that J&J might try to reel in implantable cardioverter defibrillator maker St. Jude, CFO Robert Darretta suggests the company will look for smaller targets.
You may also be interested in...
FDA To Use CDRH Dispute Resolution Panel For The First Time In Years
Device center ombudsman Weinstein refers Cardima to the DRP regarding a 2002 application.
FDA Device Center Ombudsman Fields Fewer Complaints In 2005
Communications addressed to ombudsman of FDA's device center drop to three-year low of 114, according to 2005 report.
Combination Product Submissions Rose 10% In FY 2005, FDA Says
Among the 275 applications for combination products submitted were 12 NDAs, 152 INDs and two BLAs.